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Drug resistance of bacterial pathogens is a growing problem that can be addressed
through the discovery of compounds with novel mechanisms of antibacterial activity.
Natural products, including plant phenolic compounds, are one source of diverse
chemical structures that could inhibit bacteria through novel mechanisms. However,
evaluating novel antibacterial mechanisms of action can be difficult and is uncommon
in assessments of plant phenolic compounds. With systems biology approaches,
though, antibacterial mechanisms can be assessed without the bias of target-directed
bioassays to enable the discovery of novel mechanism(s) of action against drug
resistant microorganisms. This review article summarizes the current knowledge of
antibacterial mechanisms of action of plant phenolic compounds and discusses relevant
methodology.
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INTRODUCTION
Each group of multi-drug resistant bacteria has been directly linked to thousands of deaths
annually across the globe, with resistant Shigella species and Mycobacterium tuberculosis each
causing more than one million deaths annually (WHO, 2014). In the United States (U.S.),
drug resistant bacteria are the primary cause of more than 23,000 deaths and 2 million serious
infections each year, of which resistant Clostridium difficile, Enterobacteriaceae species, and
Neisseria gonorrhoeae are considered “urgent threats” (CDC, 2013). These numbers will continue
to rise as multi-drug resistant bacteria become more prevalent; the recent documentation of
colistin-resistant Escherichia coli in the U.S. suggests that even “last resort” antibiotics with major
side effects are likely to lose their effectiveness (McGann et al., 2016).
Natural products, including compounds obtained from plants, have had renewed attention for
their diverse structures and bioactive characteristics. Phenolic compounds found in plants can be
used to combat multi-drug resistant bacteria (reviewed by Abreu et al., 2012), but their mechanisms
of action must be thoroughly characterized before they can be rationally used as antibacterial
treatments.
The general structural categories of plant-derived phenolics, as categorized by Cowan (1999),
include simple phenolics, phenolic acids, quinones, flavonoids/flavones/flavonols, coumarins, and
tannins. Although phenolics are classified as compounds with a hydroxylated aromatic ring, Cowan
categorized flavones as “phenolic structures containing one carbonyl group” (Cowan, 1999), which
prompted the inclusion of flavones in this work. A useful review of phytochemical classes and their
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general antibacterial modes of action has already been compiled
(Borges et al., 2015), as has as a detailed review of flavonoid
mechanisms of action, including cytoplasmic membrane
damage, topoisomerase inhibition, NADH-cytochrome c
reductase inhibition, and ATP synthase inhibition (Cushnie and
Lamb, 2011). More recent flavonoid reviews have focused on
mechanisms of action involving cell membranes (Tsuchiya, 2015;
Verstraeten et al., 2015). The mechanisms of action of phenolic
compounds were additionally reviewed with an emphasis on
structural features correlated to specific mechanisms (Gyawali
and Ibrahim, 2014).
Most methods to determine antibacterial mechanisms are
target-directed assays that directly test single proteins or
other cellular targets in vitro. Target-directed assays are very
informative since established bioassay protocols against a single
target can definitively assign binding and inhibitory activity
of compounds with enzymes known to be essential to cell
survival. However, target-directed assays also limit the scope
of mechanisms that can be identified, which is undesirable
when existing antibacterial mechanisms of action threaten to
become obsolete with the rise of resistant bacteria. This is
where undirected approaches like systems biology have value,
in the broad, unbiased survey of possible mechanisms that can
be used to formulate new hypotheses for novel target-directed
assays.
In this review, we aim to assess the current state of
mechanistic investigations of plant phenolic antibacterial
compounds and survey systems biology approaches that have
demonstrated success or potential for identifying antibacterial
mechanisms.
MEMBRANE DISRUPTION BY PHENOLIC
COMPOUNDS
Membrane disruption, in both Gram-positive and Gram-
negative bacteria, contributes to the antibacterial activity of
most plant phenolics that have been mechanistically assessed
(Supplementary Table 1; abbreviated in Table 1). Many of
the membrane integrity analyses cited in Supplementary
Table 1 combined several common, simple methods to monitor
the influx of hydrophobic dyes or antibiotics, the eﬄux
of intracellular constituents, and microscopic observation.
While these membrane permeability analyses provide valuable
information about membrane disruption, they give little, if
any, direction to the specific major mechanisms of action of a
compound. Furthermore, these analyses generally leave an open
question as to whether the compound altered membrane stability
by interfering with intracellular processes or by direct interaction
with membrane components. Other more unique assays have
also been conducted, for example, in the quantification of cell
surface hydrophobicity the tendency of a hydrophilic water drop
to spread or bead when in contact with a bacterial lawn was
measured (Borges et al., 2013). This assay more specifically
characterized the effect of gallic and ferulic acids, which were
observed to increase surface hydrophilicity of Gram-negative
bacteria and hydrophobicity of Gram-positive bacteria (Borges
et al., 2013). Nevertheless, this measure of surface hydrophobicity
could also be attributed to either direct interaction with the
membrane or an interaction with intracellular components that
impact cell wall chemistry.
Once a membrane effect is known to exist, specific binding
assays (Nakayama et al., 2015) or model membrane insertion
assays (Wu et al., 2013a) can confidently test direct interactions
between specific components. Model membranes have already
been used to test the direct interaction of epicatechin gallate
and epigallocatechin gallate with membranes (Hashimoto et al.,
1999; Kumazawa et al., 2004). However, the extensive diversity
in bacterial membrane composition (Sohlenkamp and Geiger,
2016) would likely require specific assays against each organism
of interest. Another unique assay that may be useful in assessing
direct membrane binding is a basic membrane integrity assay
with exogenous magnesium added. This assessment revealed a
dependence onmagnesium akin to an ethylenediaminetetraacetic
acid (EDTA) control for the membrane-disrupting activity of
gallic acid (Nohynek et al., 2006). Since magnesium ions are
known to stabilize Gram-negative bacterial membranes, this
simple assay might easily test direct membrane interactions
involving magnesium, though other integral cell functions
involving magnesium should also be considered.
A particularly in-depth study was conducted for
epigallocatechin gallate’s mechanism of action against
methicillin-resistant Staphylococcus aureus (MRSA) and its
contribution to renewed beta-lactam susceptibility. The study
assessed purified cell wall components, phosphorus content,
the effects of exogenous peptidoglycan on activity, adherence
to glass, penicillin binding protein abundance, Triton-X-100
autolysis, bacteriolytic enzymes, free lipoteichoic acid, and
lysostaphin’s pentaglycine cleavage activity. Each of these
methods focused on addressing a particular hypothesis of
epigallocatechin gallate’s mechanism of action, which is an ideal,
albeit time-consuming, approach for a mechanistic assessment.
Nevertheless, the specific mechanism of action remained
unknown despite the new knowledge of epigallocatechin gallate’s
observed effects on cell adherence, autolysin accumulation, and
lipoteichoic acid release (Stapleton et al., 2007). Another method
that has given mechanistic insight, but not a specific mechanism
of action, was the use of high resolution gas chromatography
(HRGC) lipid profiling to identify specific lipids altered by the
presence of eugenol, carvacrol, or thymol in both Gram-negative
and Gram-positive bacteria (Di Pasqua et al., 2007). All three
tested phenolics were observed to increase major fatty acids
(palmitic, oleic, cis-10 heptadecenoic acids) in Gram-negative
bacteria while Gram-positive S. aureus lipid profiles changed
across several fatty acids. S. aureus treatment with thymol,
though, resulted in a clear increase in saturated fatty acids and
decrease in unsaturated fatty acids, which could be due to a
desaturase response to cell leakage (Di Pasqua et al., 2007).
While this type of untargeted assessment requires interpretation,
it gives a greater depth of information than most of the basic
membrane disruption assays. When iterations of logically
planned assays are performed, a good depth of information
is also obtained. However, conducting iterations of assays is
time and labor intensive while HRGC can gather information
on many potential targets simultaneously. Although no liquid
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chromatography-mass spectrometry (LC-MS) lipidomics
experiments to deduce the mechanisms of action of a phenolic
were found in the literature, a basic LC-MS experiment can
measure an even larger range of metabolites than HRGC and
more confidently identify them; this technology can profile
the relative abundance of thousands of lipids simultaneously
and is easily automated (Wenk, 2005). Using more untargeted
approaches capable of profiling thousands of compounds in
a single experiment will be useful in the rapid generation of
mechanistic hypotheses that can subsequently be tested with a
relevant subset of targeted assays.
NON-MEMBRANE MECHANISMS OF
ACTION
Assessments for non-membrane mechanisms of action can also
be categorized into target-directed assays for knownmechanisms
of action and undirected experiments that take a systems-
wide approach to exploring mechanisms of action. Among
the plant phenolics tested in Supplementary Table 1, targeted
assays have discovered DNA gyrase inhibitory activity for 11
phenolic compounds (Ohemeng et al., 1993; Wu et al., 2013b),
type III secretion inhibition for 9 compounds (Tsou et al.,
2016), inhibition of helicase activity for 5 phenolic compounds
(Xu et al., 2001), multi-drug eﬄux pump inhibitors for 3
compounds (Smith et al., 2007; Fiamegos et al., 2011; Bag and
Chattopadhyay, 2014), dehydratase inhibition for 3 compounds
(Zhang et al., 2008), protein kinase inhibition for 2 compounds
(Shakya et al., 2011), and single phenolic compounds among
which one inhibited urease activity (Moon et al., 2013), one
bound iron (Chung et al., 1998), one inhibited succinate
dehydrogenase and malate dehydrogenase (Yao et al., 2012), one
intercalated into DNA (Lou et al., 2012), one induced DNA
fragmentation, an ROS response, and suppressed FtsZ expression
(Hwang and Lim, 2015), and one bound to the FtsZ protein
and inhibited FtsZ assembly (Rai et al., 2008). Many of these
results clearly come from large experimental activity screens in
which several phenolic compounds were assessed for a single
mechanism of action. This single mechanism screening approach
generates valuable information andmore such screens are needed
to assess phenolic antibacterial mechanisms. Nevertheless, the
major mechanism(s) of action of a compound could easily
be overlooked with a screening approach if confounding
multiple mechanisms exist for the target compound. This
problem seems likely when looking at one of the most-studied
phenolics, quercetin, and its diverse list of mechanisms of action
[cell membrane disruption, DNA intercalation, DNA gyrase
inhibition, type III secretion inactivation, dehydratase inhibition
(HpFabZ), and protein kinase inhibition; Table 1].
A general methodological approach to these targeted
assessments was to verify antibacterial activity, purify the target
enzyme, and characterize its phenolic-bound and unbound
structures using spectrophotometric techniques. As an example,
after gathering antibacterial activity data and purifying the FtsZ
enzyme, curcumin was observed to inhibit the FtsZ protofilament
assembly by monitoring assembly kinetics with light scattering,
to bind to purified FtsZ based on an increase in bound-curcumin
fluorescence at 495 nm, and was noted to alter the secondary
structure of FtsZ based on a circular dichroism analysis (Rai
et al., 2008). In some studies, however, only inhibitory activity
was determined and structural binding characteristics were
not assessed (Ohemeng et al., 1993; Smith et al., 2007; Bag and
Chattopadhyay, 2014). The most specific interaction details
were found by the two studies that obtained crystal structures
of quercetin or apigenin bound to the enzymes they inhibited
(Zhang et al., 2008; Shakya et al., 2011). One of these studies
moved to the next step in mechanistic understanding by
introducing a single amino acid mutation to the enzyme in
order to verify the importance of a key binding interaction
(Zhang et al., 2008). Unfortunately, the conserved tyrosine that
was mutated did not alter binding, so the specific, necessary
interaction points between quercetin or apigenin and FabZ
still need to be validated (Zhang et al., 2008). Two additional
studies were performed in which detailed structure mechanisms
were determined with molecular docking (Plaper et al., 2003;
Fiamegos et al., 2011). Detailed structural characterizations of
phenolic binding mechanisms are a valuable contribution to the
field that can facilitate successful computational prioritizations
of potentially active compounds and predictions of compound
activities to guide both natural product testing and rational
antibacterial design.
Only one study in Supplementary Table 1 that is not
membrane-specific can be called untargeted: the proteomics
assessment of thymol antibacterial activity against Salmonella
Thompson (Di Pasqua et al., 2010). Researchers found altered
abundances of citric acid cycle enzymes, ATP synthesis enzymes,
stress-related chaperone proteins, cell envelope proteins, and
an absence of the antioxidant protein thioredoxin 1 in treated
cells. Although a specific mechanism of action was not identified
here, valuable information was produced that verified the cell
membrane disruption observed in other thymol-treated Gram-
negative bacteria and added several additional possible protein
targets. Additional assays to test different portions of the
impacted pathways, thioredoxin, and relevant regulatory proteins
are still needed, of course, but it is now clear that membrane
disruption alone was not the sole mechanism of action of thymol
against S. Thompson and that intracellular proteins, including
thioredoxin, may be important targets (Di Pasqua et al., 2010).
KEY FUNCTIONAL CHARACTERISTICS
Mechanisms characterized to the level of atomic interaction
points are rare in the examples of Supplementary Table 1, but
give themost specificmechanistic information. Crystal structures
of FabZ with quercetin or apigenin as ligands revealed that
both ligands similarly blocked substrates from passing through
a tunnel to reach the FabZ active site (Zhang et al., 2008).
Hydrophobic interactions likely sandwiched the phenolic ring
of quercetin or apigenin between a tyrosine and proline in one
binding site and between a phenylalanine and an isoleucine
in a second binding site (Figure 1). In the crystal structure of
quercetin-bound resistance kinases, hydrogen bonds between
Frontiers in Microbiology | www.frontiersin.org 4 March 2017 | Volume 8 | Article 422
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FIGURE 1 | Known binding sites of phenolic compounds and their antibacterial targets from crystal structure data. Quercetin was observed to bind to the
Helicobacter pylori beta-hydroxyacyl-acyl carrier protein (HpFabZ) at two sites (A,B; PDB structure 3CF8), apigenin bound to HpFabZ at the same two sites (C,D;
PDB structure 3CF9), and quercetin bound to the kinase APH(2′′)-IVa in three locations [E,F,G; PDB structure 4DFU (formerly 3R82)]. Isolated black spheres represent
water and isolated gray spheres represent chloride ions. The ligand is in ball-and-stick representation while the protein side chains in contact range are in stick
representation. PDB, protein data bank. This figure was made with BALLView (Moll et al., 2006).
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hydroxyl groups, and nearby amino acids appeared to be the
primary interactions (Shakya et al., 2011; Figure 1). Based on
several flavonoids tested, the absence of a particular carbonyl
group was necessary for binding and the hydroxyl position was
important (Shakya et al., 2011). In a molecular docking study
of quercetin and DNA gyrase, it was proposed that quercetin
has one mechanism by which it binds DNA, stabilizes the DNA-
gyrase complex, and induces DNA cleavage in addition to a
second mechanism by which it inhibits DNA supercoiling by
competitively binding to the ATP binding site of the DNA gyrase
B subunit (Plaper et al., 2003). Another molecular docking study
surveyed the localization of caffeoylquinic acids to an eﬄux
pump and determined that caffeoylquinic acids tended to bind
in a position that blocked the eﬄux pump (Fiamegos et al., 2011).
Similar trends in functional groups that contribute to
bioactivity are seen in many structure-activity relationship
studies. Electron distribution, as impacted by the number and
location of hydroxyl groups and double bonds, has been the
major factor associated with antibacterial activity of flavonoids
(reviewed by Shapiro and Guggenheim, 1998; Wu et al., 2013a,b;
Gyawali and Ibrahim, 2014). Electron localization and other
structural features also impact molecular hydrophobicity, which
impacts the types of membrane interactions that are possible.
Other studies have found hydroxyl counts and positions
to be important for bioactivity extending beyond flavonoids
and into the broader category of phenolics. A quantitative
structure activity relationship (QSAR) analysis with more than
100 phenolics and related compounds used MIC doses for the
oral bacteria Porphyomonas gingivalis, Selenomonas artemidis,
and Streptococcus sobrinus and found that a hydroxyl group
attached to an aromatic ring was required for low MICs (Shapiro
and Guggenheim, 1998). Exceptions to the general trend of
key hydroxyl placement have been observed through isomers
that had different antibacterial activities, suggesting that chirality
is also an important factor (Friedman et al., 2002; reviewed
by Gyawali and Ibrahim, 2014). Interestingly, the number of
hydroxyl groups has also been correlated with antioxidant
activity (reviewed by Rice-Evans et al., 1996; Balasundram et al.,
2006). However, any relationship between antioxidant activity
and antibacterial activity is not fully understood.
SYNERGISTIC ANTIBACTERIAL ACTIVITY
If specific mechanisms of action are known, phenolic compounds
can be rationally combined with other antibacterial compounds
to synergistically combat multi-drug resistant bacteria.
Synergistic effects have already been observed for many
phenolic compounds when combined with antibiotics currently
in use (reviewed by Aiyegoro and Okoh, 2009; Hemaiswarya
and Doble, 2010; Amin et al., 2015; essential oil components
reviewed by Langeveld et al., 2014; Oh and Jeon, 2015; Lim
et al., 2016). Many synergistic effects have been attributed to
membrane-disrupting compounds, including phenolics, which
allow intracellular toxins faster/easier access to their targets
(Hemaiswarya and Doble, 2010; Amin et al., 2015; Oh and
Jeon, 2015). Additionally, strains that use eﬄux pumps to
remove toxins can be attacked by blocking the eﬄux pumps
with one compound and applying an intracellular toxin as a
second compound for synergistic killing (Oh and Jeon, 2015;
reviewed by Tegos and Stermitz, 2002; Prasch and Bucar, 2015).
The down-regulation of eﬄux pump expression has also been
observed (Oh and Jeon, 2015). Synergistic effects between
other modes of action may also exist and could improve the
functionality of existing antibacterial compounds, especially in
combating drug resistance mechanisms.
MAMMALIAN TOXICITY
Many phenolic compounds have been tested for their cytotoxicity
against different cancer cell lines, but limited information
is available for effects on non-tumorigenic cells or whole
organisms. Vanillin is one compound with a clear toxicity
rating in the literature; it is considered non-toxic at typical
exposure concentrations with an LD50 of 3500–4000 mg/kg
in acute toxicity tests in rats based on assays summarized by
the Organization for Economic Co-operation and Development
(OECD). In vivo studies in mice showed no genotoxicity and
vanillin was actually observed to decrease the mutagenic effect
of the positive controls mitomycin C and ethylnitrosourea in
mouse micronucleus assays (OECD SIDS, 1996). Other phenolic
compounds have been extensively reviewed for their toxic
properties by Galati and O’Brien (2004), who highlighted the
pro-oxidant effects of compounds in the presence of metals
and peroxidases, DNA binding of compounds with catechol
groups, and mouse hepatotoxicity of epicatechin gallate and
propyl gallate. While most compounds derived from edible
plants, including phenolics, are considered safe at common
levels of consumption, rigorous toxicity testing must be done
to ensure safety at different concentrations and in different
conditions.
SYSTEMS BIOLOGY METHODS
Phenolic compounds from natural sources have been assessed
for antibacterial mechanisms related to membranes and specific
protein and/or pathway targets (Supplementary Table 1;
Figure 2). However, most of these assays are limited to target-
directed tests of known antibacterial mechanisms and do not
facilitate the discovery of novel mechanisms of action or multiple
mechanisms of action. Increasing the use of undirected systems
biology approaches (summarized in Table 2) could reveal the
major known and/or unknown mechanism(s) of action.
A small set of systems biology approaches are limited to
assessing known antibacterial mechanisms and can thus be
considered target-directed. These include chemical-genetic and
chemical-chemical interaction approaches. Chemical-genetic
approaches collect a genetic “fingerprint” from the effect of
antibiotic treatment on a collection of overexpression and
deletion mutants that can be used to generate hypotheses about
mechanism of action. Similarly, chemical-chemical interaction
analyses collect a “fingerprint” of synergistic data using pairwise
combinations of the unknown chemical and chemicals with
known mechanisms. These methods have had success, as
reviewed in Farha and Brown (2016), but are limited to the
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FIGURE 2 | Antibacterial mechanisms of action summarized for (A) common antibiotic classes and (B) plant phenolic compounds (adapted from Helander
et al., 1997; Kohanski et al., 2010; Brown et al., 2015). PBP, penicillin binding protein. Effects of exogenous magnesium were not tested on a Gram-positive organism,
only a Gram-negative organism.
characterized mutants or chemicals of known mechanism that
are used in the assessments.
Other systems biology approaches are diverse, but use
an undirected approach to survey sets of biomolecules
that allows for the discovery of novel antibacterial targets.
Proteomics approaches have been particularly popular for the
discovery of small molecule binding targets since definitive
evidence of protein-ligand binding can be obtained. Affinity
chromatography, phage display of peptides, and protein
microarrays have been used to effectively isolate binding targets
Frontiers in Microbiology | www.frontiersin.org 7 March 2017 | Volume 8 | Article 422
Rempe et al. Phenolic Antibacterial Mechanisms
TABLE 2 | Summary of systems biology methods for the determination of antibacterial mechanism of action.
Method Information obtained Advantages Limitations
Chemical-chemical screen A “fingerprint” of synergy interactions
between the chemical of interest and
compounds with known antimicrobial
activity
Can develop hypotheses about
mechanisms of action
Limited to hypotheses based on
known mechanisms of action,
pairwise synergy tests may be
large and time-consuming
Chemical-genetic screen A “fingerprint” of activity profiles of a set of
deletion and overexpression mutants
Can develop hypotheses about
mechanisms of action
Limited to mechanisms related
to mutants
Proteomics Affinity chromatography Identifies interactions between a tagged
antimicrobial compound and any protein
Definitive evidence of protein-ligand
interactions
Requires strong protein-ligand
affinity, misses low-abundant
proteins, requires ligand tag that
does not inactivate antimicrobial
activity
Phage display Identifies interactions with
phage-expressed proteins
Definitive evidence of protein-ligand
interactions, can capture
low-abundance proteins
Eukaryotic proteins may be
mistranslated or misfolded, may
be non-specific binding, not
good for multimeric or
transmembrane proteins
Microarray Identifies interactions with purified proteins
attached to a slide
Definitive evidence of protein-ligand
interactions
Difficult to purify many proteins
for a protein microarray
Expression analysis All proteins altered by the presence of an
antimicrobial are observed
Patterns in expressed proteins can
reveal specific antimicrobial
mechanisms
Data interpretation can be
difficult
Transcriptomics Microarray Survey of expression altered by
antimicrobial compound
Patterns in transcribed RNA can
reveal specific antimicrobial
mechanisms
Limited to known transcripts,
data interpretation can be difficult
RNA-seq All transcripts altered by the presence of
an antimicrobial are observed
Patterns in transcribed RNA can
reveal specific antimicrobial
mechanisms
Data interpretation can be
difficult
Metabolomics All metabolites altered by the presence of
an antimicrobial are observed
Patterns in metabolites can reveal
specific antimicrobial mechanisms
Data interpretation can be
difficult
Genomics of screened mutants Genetic mutant bacteria with resistance to
the tested antimicrobial are sequenced to
identify the mutation
Mutations found in the genome can
give direct evidence of mechanism of
action
Mutations may merely reveal a
generic resistance response (i.e.,
multi-drug efflux pump activity)
Screening for targets Screen for possible antimicrobial targets,
then use target-directed screens to
evaluate targets
Identifies putative targets Limited by target selection
criteria, limited by diversity of
chemical structures in the
second step of target-directed
screening, has had very minimal
success in the past
Structural systems pharmacology Acquire data from multiple-omics
technologies, develop hypotheses/models
of system
Integrating multiple types of data can
give more specific and conclusive
evidence of mechanisms of action
Data interpretation can be
difficult
of small molecules for separation and subsequent identification
with mass spectrometry. These proteomic techniques have
already been thoroughly reviewed (Wong et al., 2008; Ziegler
et al., 2013). Expression proteomics can also be effective in
identifying mechanisms of action based on identifying proteins
differentially expressed with an antibacterial treatment. Recently,
expression proteomics showed its usefulness in mechanistic
assessments by providing evidence for a second mechanism of
action of the atypical tetracycline chelocardin, which inhibits
peptidyl transferase at low concentrations and causes membrane
depolarization at high concentrations in B. subtilis (Stepanek
et al., 2016).
Metabolomics has also proven useful for determining
mechanisms of action that impact specific metabolic functions.
The mechanisms of action of a thymidine kinase inhibitor (AZ1),
a 1-deoxy-D-xylulose-5-phosphate (DXR) pathway inhibitor
(fosmidomycin), and a lipid A synthesis inhibitor (CHIR-
090) were readily identified from E. coli metabolomics data
by researchers blinded to the antibiotics used (Vincent et al.,
2016). However, in the analysis of other compounds, the
metabolomics data showed non-specific upregulation of many
metabolites for a peptidoglycan cross-linking inhibitor, a DNA
ligase inhibitor, and an enoyl-acyl carrier protein inhibitor.
Furthermore, no discernible metabolic differences were observed
between a control and an antibiotic treatment that uncoupled the
proton gradient of the electron transport chain. Measurement
limitations in observing peptidoglycan molecules (too large)
and mono-, di-, and tri-phosphates (differing ionizabilities)
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were possible reasons for the lack of relevant information
from the peptidoglycan inhibitor and oxidative phosphorylation
inhibitor (Vincent et al., 2016). Researchers were also able
to differentiate antibacterial compounds based on the affected
E. coli metabolome after 60 and 90 min of treatment, but
not after 30 min (Belenky et al., 2015). It was not specified
whether the known cellular targets of ampicillin, kanamycin,
and norfloxacin could be determined from their respective
metabolomes, but the ROS hypothesis of cell death, which
theorizes that ROSs induce cell death in all antibacterial
mechanisms of action, was supported based on similarly
high levels of a metabolic marker for DNA/RNA oxidation
across all antibiotic treatments (Belenky et al., 2015). Another
metabolomic study successfully used the exometabolome of
S. aureus to determine the previously unknown antibacterial
mechanism of action of triphenylbismuthdichloride (TPBC). By
comparing the exometabolome of TPBC-treated S. aureus to
the exometabolomes of kanamycin, ciprofloxacin, trimethoprim,
and fluoropyruvate it was observed that only TPBC and
fluoropyruvate treatments resulted in continuously accumulated
pyruvate. Thus, it was hypothesized that TPBC had pyruvate
dehydrogenase inhibition activity, which was verified by an
enzyme activity assay with cell lysate (Birkenstock et al., 2012).
Another study used a similar comparison methodology to
hypothesize the mechanism of the non-phenolic plant natural
product dihydrocucurbitacin F-25-O-acetate. The metabolic
profile of S. aureus treated with dihydrocucurbitacin F-25-O-
acetate clustered with the metabolic profile of S. aureus treated
with vancomycin, a known inhibitor of peptidoglycan synthesis
(Biao-Yi et al., 2008).
A scheme to classify compounds into known mechanisms of
action was also recently used with NMR metabolomics, where
a partial least squares discriminant analysis of the metabolic
“fingerprints” of E. coli treated with one of nine antibiotics
of known mechanism gave 91% accuracy with intracellular
data and 30% accuracy with extracellular data (Hoerr et al.,
2016). Another systems biology approach similarly classified
phenotypes based on the Raman spectra of dried E. coli cells to
distinguish antibacterial mechanisms of action; 15 antibacterial
compounds representing protein synthesis inhibitors, cell wall
synthesis inhibitors, DNA synthesis inhibitors, and RNA
synthesis inhibitors were differentiable with 83.6% accuracy by
mechanistic class. Ampicillin was always incorrectly classified
with the final model based on a linear discriminant analysis
of principle components, but overlap between the mechanism
groups could explain this and other misclassification tendencies
(Athamneh et al., 2014). Classification schemes like these can
only classify data into known mechanisms of action. However,
such best fit classifications can potentially be of value by singling
out unknown mechanisms of action that do not group into
known mechanistic classes.
Another systems approach is the high-throughput but still
time intensive method of screening for novel targets by, e.g.,
using genomes to identify genes that are conserved in multiple
bacterial organisms followed by in vitro enzyme assays to
screen for inhibitors of purified targets (discussed by Miesel
et al., 2003; Payne et al., 2007; Harvey et al., 2015). This
approach was widely adopted by industry when basic screens
for antibacterial activity began to reveal the same set of
common antibacterial compounds. However, it was surprisingly
unsuccessful at identifying novel compounds, possibly due to
poor selection of targets and chemical diversity in the libraries
used to screen selected targets (discussed by Payne et al., 2007;
Harvey et al., 2015).
Transcriptomic studies have tended to highlight pathways
impacted by an antibacterial compound without identifying
a specific mechanism of action (Yu et al., 2012; Elnakady
et al., 2016), although transcriptional profiling of bacterial
mutants revealed expression trends that were used to predict
phenylalanyl-tRNA synthetase inhibition and bacterial acetyl
coenzyme A carboxylase inhibition as the primary mechanisms
of action of two novel antibacterial compounds (Freiberg et al.,
2005). A 2004 review cites transcriptomic and proteomic studies
that assessed antibacterial mechanisms, some of which were
successful in identifying mechanisms of action (Freiberg et al.,
2004).
Structural systems pharmacology has also made strides
in identifying antibacterial mechanisms through combining
multiple-omics approaches. A recent study was able to use an E.
coli K12 genome scale metabolic model integrated with protein
structures to correctly predict the antibacterial mechanisms of
fosfomycin, and sulfathiazole. This model was also able to
predict additional mechanisms of action for (1-hydroxyheptane-
1,1-diyl)bis(phosphonic acid) and cholesteryl oleate and predict
potential inhibitors of a protein target (tryptophan synthase beta
subunit) with no previously known inhibitors. However, many
false positives were also observed, which could be attributed
to the static protein structures used to evaluate ligand binding
(Chang et al., 2013).
The major limitations of -omics approaches are the ranges of
detection for different technologies, the availability of annotated
information for a given organism, and data interpretation
challenges. As an example, metabolomics high resolution
LC-MS systems can give a good representation of major
bacterial metabolic pathways, but lipids, high molecular-weight
compounds, and volatile compounds generally require separate
runs on different instrument platforms (reviewed by Dettmer
et al., 2007; Aretz and Meierhofer, 2016). On the annotation
aspect, bacterial pathogens have long been a focal point of
bacterial research, so they are relatively well-studied and have
readily accessible, consistently annotated databases specifically
dedicated to pathogens (Wattam et al., 2014), though annotated
genomes, transcriptomes, proteomes, and metabolomes in
general are still far from comprehensive (Médigue and Moszer,
2007; Aretz and Meierhofer, 2016). The large scale of data
generated by -omics technologies can be challenging to analyze
and may not be useful in antibacterial target discovery if
generic widespread stress effects occur or if no visible effects are
observed. However, successes have already been observed and the
need for novel antibacterial approaches necessitates undirected
approaches that allow for the discovery of novel mechanisms
of action. Moving forward, proteomics, and metabolomics seem
particularly promising since they have successfully contributed to
several determinations of antibacterial mechanisms of action. As
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reference libraries of peptides and metabolites expand, we expect
these –omics technologies to be integrated into antibacterial
discovery pipelines to guide targeted assays and allow for the
discovery of novel mechanisms of action.
CONCLUSION
The mechanisms of action of most naturally derived phenolic
compounds are not well-characterized. Of the compounds
reviewed here, mechanistic assessments have found specific
antibacterial targets, including DNA, DNA gyrase, multi-
drug eﬄux pumps, FabZ, protein kinases, helicase, and FtsZ.
The identification of these antibacterial targets through
target-directed methods enables the rational use of phenolic
compounds against bacterial pathogens susceptible to these
known mechanisms of action. However, target-directed
approaches have no opportunity to discover novel mechanisms
of action, which is a necessary step to combat multi-drug
resistant bacteria. A systems-biology approach to investigating
the antibacterial mechanisms of phenolic compounds is not yet
common in determining phenolic antibacterial mechanisms of
action, but will likely push the field forward by speeding up
mechanistic determinations and removing the bias of testing for
currently known mechanisms.
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